The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global microencapsulation market reached a value of US$ 8.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 16 Billion by 2027, exhibiting at a CAGR of 9.98% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Microencapsulation refers to a protective technology that helps encapsulate solid, liquid, or gaseous material into microparticles. The material enclosed is generally released in a variety of ways, such as physical pressure, friction, diffusion, wall dissolution, and biodegradation. Microencapsulation offers numerous advantages, which include improved efficacy, reduced toxicity, and enhanced patient compliance and convenience compared to conventional dosage forms. Besides this, it also assists in prolonging the action of drugs, solidifying liquids, and improving the stability of thermochromic mixtures. As a result, it finds extensive applications in end use industries around the world.
The flourishing pharmaceutical industry on account of the growing prevalence of chronic diseases represents one of the key factors strengthening the growth of the market. Microencapsulation is increasingly being used to reduce the adverse effect, improve therapeutic efficacy by targeting the intended site, and control drug release from encapsulated microparticles. Apart from this, it also helps enhance the stability of drugs by forming a barrier between drug and external environment and solubility of poorly soluble drugs by particle size reduction. Additionally, as the food and beverage (F&B) industry employs functional ingredients to improve flavor, color, and texture properties, and extend the shelf-life of products, there is a rise in the demand for highly efficient microcapsules worldwide. This can be accredited to the benefits of the spray-drying technique that has a low cost and high drug-loading efficacy. Furthermore, leading market players are continuously funding research and development (R&D) activities to improve technology efficiency, which is creating a favorable market outlook. Besides this, significant adoption of microencapsulation techniques in the agrochemical industry is anticipated to propel the market across the globe.
IMARC Group provides an analysis of the key trends in each sub-segment of the global microencapsulation market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on coating material, core form, technology and application.
Breakup by Coating Material:
Breakup by Core Form:
Breakup by Technology:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AVEKA Group, Balchem Inc., BASF SE, Bayer AG, Capsulae, Cargill Incorporated, DuPont de Nemours Inc., Encapsys LLC, Koehler Innovative Solutions, Koninklijke DSM N.V., Lycored, Reed Pacific, Syngenta Group (China National Chemical Corporation) and TasteTech.
|Base Year of the Analysis||2021|
|Segment Coverage||Coating Material, Core Form, Technology, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||AVEKA Group, Balchem Inc., BASF SE, Bayer AG, Capsulae, Cargill Incorporated, DuPont de Nemours Inc., Encapsys LLC, Koehler Innovative Solutions, Koninklijke DSM N.V., Lycored, Reed Pacific, Syngenta Group (China National Chemical Corporation) and TasteTech|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at